Cantex Pharmaceuticals’ CX-01 receives FDA fast track designation in acute myeloid leukemia

pharmanewsdaily- August 27, 2018 0

Cantex Pharmaceuticals, a Florida-based biotechnology company, has achieved a significant milestone by securing Fast Track designation from the US Food and Drug Administration (FDA) for ... Read More